ABBV – AbbVie Inc. – Fundamental analysis, financial statements, key ratios, and fair value analysis

AbbVie Inc.

Healthcare
Drug Manufacturers – Major
89.07
2.78
3.22%
123.21
77.85
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)4.79
EPS Estimate Currrent Qtr1.92
Book Value Per Share-1.94
Market Cap 134 Billion
PE Ratio 18.4
Dividend Yield4.8068285

Stock Yield

Stock Return 7 Days8.27%
Stock Return 15 Days7.29%
Stock Return 30 Days -2.71%
Stock Return 3 Months-3.30%
Stock Return One Year-5.77%
Stock Return 3 Years-4.67%

Stock Technical Analysis

Relative Strengh Index (14)44.77
Average True Range (14)3.31
Momentum (14)-2.31
Simple Moving Average (14) -2.31
Time Series Forecast (14)89.13
Time Series Forecast (30) 90.56

Stock News

Financial Statements

index2014201520162017
Revenue20 Billion23 Billion26 Billion28 Billion
Cost of Revenue4 Billion4 Billion6 Billion7 Billion
Gross Profit16 Billion18 Billion20 Billion21 Billion
Gross Margin (%)77.83%80.31%77.25%75.05%
Selling General and Administrative Expense8 Billion6 Billion6 Billion6 Billion
Other operating expenses5 Billion5 Billion5 Billion6 Billion
Earning Before Interest and Taxes EBIT3 Billion7 Billion9 Billion9 Billion
EBIT/Operating Margin (%)13.83%32.07%34.52%30.94%
Interest Expense391 Million686 Million965 Million1 Billion
Other non-operating expenses/income0000
Earnings before Tax2 Billion7 Billion8 Billion8 Billion
Income Tax Expense595 Million2 Billion2 Billion2 Billion
Net Income2 Billion5 Billion6 Billion5 Billion
Net Margin (%)8.89%22.50%23.22%18.82%
Earnings per share from operating income1.414370.4553210.4094980.498353
Earnings per Diluted Share1.13.133.633.3
Dividends per Basic Common Share1.662.022.282.56
Payout ratio0.6626511.54951.592111.28906
Weighted average number of shares outstanding2 Billion2 Billion2 Billion2 Billion
index2017 Q42018 Q12018 Q22018 Q3
Revenue8 Billion8 Billion8 Billion8 Billion
Cost of Revenue2 Billion2 Billion2 Billion2 Billion
Gross Profit5 Billion6 Billion6 Billion6 Billion
Gross Margin (%)70.54%75.71%76.64%77.72%
Selling General and Administrative Expense2 Billion2 Billion2 Billion2 Billion
Other operating expenses2 Billion1 Billion2 Billion1 Billion
Earning Before Interest and Taxes EBIT1 Billion3 Billion2 Billion3 Billion
EBIT/Operating Margin (%)18.67%38.42%27.59%37.19%
Interest Expense252 Million251 Million272 Million302 Million
Other non-operating expenses/income0000
Earnings before Tax1 Billion3 Billion2 Billion3 Billion
Income Tax Expense1 Billion14 Million29 Million14 Million
Net Income52 Million3 Billion2 Billion3 Billion
Net Margin (%)0.67%35.08%23.96%33.35%
Earnings per share from operating income926.2820.6294370.9141190.616041
Earnings per Diluted Share0.031.741.261.81
Dividends per Basic Common Share0.640.710.960.96
Payout ratio0.0468752.45071.31251.88542
Weighted average number of shares outstanding2 Billion2 Billion2 Billion2 Billion
index2014201520162017
Cash and Equivalents8 Billion8 Billion5 Billion9 Billion
Trade and Non Trade Receivables4 Billion5 Billion5 Billion5 Billion
Inventory1 Billion2 Billion1 Billion2 Billion
Other current assets20 Billion18 Billion15 Billion24 Billion
Current Assets16 Billion16 Billion16 Billion21 Billion
Total Non-Current Assets11 Billion37 Billion50 Billion50 Billion
Total Assets28 Billion53 Billion66 Billion71 Billion
Trade and Non Trade Payables7 Billion8 Billion9 Billion10 Billion
Other current liabilities4 Billion2 Billion402 Million6 Billion
Current Liabilities11 Billion11 Billion10 Billion17 Billion
Liabilities Non Current14 Billion38 Billion52 Billion49 Billion
Accumulated Retained Earnings Deficit535 Million2 Billion4 Billion5 Billion
Shareholder’s equity other1 Billion2 Billion258 Million-362 Million
Shareholders Equity2 Billion4 Billion5 Billion5 Billion
Noncontrolling interests23 Billion22 Billion20 Billion33 Billion
Total Assets28 Billion53 Billion66 Billion71 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents9 Billion9 Billion4 Billion8 Billion
Trade and Non Trade Receivables5 Billion6 Billion6 Billion6 Billion
Inventory2 Billion2 Billion2 Billion2 Billion
Other current assets24 Billion22 Billion10 Billion19 Billion
Current Assets21 Billion20 Billion14 Billion18 Billion
Total Non-Current Assets50 Billion49 Billion48 Billion48 Billion
Total Assets71 Billion69 Billion62 Billion66 Billion
Trade and Non Trade Payables10 Billion11 Billion11 Billion11 Billion
Other current liabilities6 Billion6 Billion7 Billion4 Billion
Current Liabilities17 Billion17 Billion17 Billion15 Billion
Liabilities Non Current49 Billion49 Billion48 Billion54 Billion
Accumulated Retained Earnings Deficit5 Billion5 Billion5 Billion7 Billion
Shareholder’s equity other-362 Million-1 Billion-9 Billion-10 Billion
Shareholders Equity5 Billion4 Billion-3 Billion-3 Billion
Noncontrolling interests33 Billion34 Billion34 Billion31 Billion
Total Assets71 Billion69 Billion62 Billion66 Billion
index2014201520162017
Net Cash Flow from Operations4 Billion8 Billion7 Billion10 Billion
Capital Expenditure-612 Million-532 Million-479 Million-529 Million
Net Cash Flow from Investing-926 Million-13 Billion-6 Billion-274 Million
Net Cash Flow from Financing-3 Billion6 Billion-4 Billion-6 Billion
Cash and Equivalents8 Billion8 Billion5 Billion9 Billion
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations3 Billion3 Billion3 Billion5 Billion
Capital Expenditure-182 Million-119 Million-114 Million-282 Million
Net Cash Flow from Investing201 Million-447 Million687 Million-963 Million
Net Cash Flow from Financing-2 Billion-3 Billion-9 Billion916 Million
Cash and Equivalents9 Billion9 Billion4 Billion8 Billion

Stock Price History

table